Analyst stock forecast
First Tracks Biotherapeutics, Inc. - Ordinary Shares Stock Forecast and Analyst Price Target
TRAX analyst target range, upside, consensus rating and coverage count.
Direct answer
First Tracks Biotherapeutics, Inc. - Ordinary Shares's average price target is $53.25.
The target implies +15.4% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $30.00 to $70.00, with 8 analysts in the current consensus when available.
Forecast evidence checked August 13, 2026.
Get free First Tracks Biotherapeutics, Inc. - Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.13
- Average price target
- $53.25
- High price target
- $70.00
- Low price target
- $30.00
- Target upside
- +15.4%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026
Explore related company data
View First Tracks Biotherapeutics, Inc. - Ordinary Shares's price target rangeView First Tracks Biotherapeutics, Inc. - Ordinary Shares's target upside or downsideView First Tracks Biotherapeutics, Inc. - Ordinary Shares's analyst consensus ratingReturn to First Tracks Biotherapeutics, Inc. - Ordinary Shares profile